DOCSLIB.ORG

Endogenous Fatty Acids Are Essential Signaling Factors of Pancreatic Β

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Endogenous Fatty Acids Are Essential Signaling Factors of Pancreatic Β 1986 Diabetes Volume 67, October 2018 Endogenous Fatty Acids Are Essential Signaling Factors of Pancreatic b-Cells and Insulin Secretion Sebastian Hauke,1 Kaya Keutler,1,2 Prasad Phapale,1 Dmytro A. Yushchenko,1,3 and Carsten Schultz1,2 Diabetes 2018;67:1986–1998 | https://doi.org/10.2337/db17-1215 The secretion of insulin from b-cells depends on extra- insulin is required to sustain normoglycemia compared cellular factors, in particular glucose and other small with a constant insulin supply (2). Disturbed synchronized molecules, some of which act on G-protein–coupled oscillatory insulin secretion was found in hyperglycemic receptors. Fatty acids (FAs) have been discussed as and hyperinsulinemic ob/ob mice and was suggested to exogenous secretagogues of insulin for decades, espe- contribute to insulin resistance and to the development of cially after the FA receptor GPR40 (G-protein–coupled type 2 diabetes mellitus (3). The coordination of islets in receptor 40) was discovered. However, the role of FAs the pancreas, in addition to gap junctions (4), relies on as endogenous signaling factors has not been investi- indirect intercellular communication (i.e., on soluble mes- gated until now. In the present work, we demonstrate sengers that reach b-cells by diffusion in the intercellular that lowering endogenous FA levels in b-cell medium by space of islets and across pancreatic lobes) (5). Individual stringent washing or by the application of FA-free (FAF) b-cell activity as well as cell-to-cell coordination in pan- BSA immediately reduced glucose-induced oscillations 2+ 2+ creatic islets are predominantly fine-tuned by the close of cytosolic Ca ([Ca ]i oscillations) in MIN6 cells and mouse primary b-cells, as well as insulin secretion. Mass coordination of a multitude of diffusible factors that os- spectrometry confirmed BSA-mediated removal of FAs, cillate in the extracellular space. This includes a number of with palmitic, stearic, oleic, and elaidic acid being the most neurotransmitters and hormones, such as g-aminobutyric abundant species. [Ca2+] oscillations in MIN6 cells recov- acid (6) and neuropeptide Y (7). In particular, b-cells are i – ered when BSA was replaced by buffer or as FA levels in the equipped with many G-protein coupled receptors, which SIGNAL TRANSDUCTION 2+ supernatant were restored. This was achieved by recombi- are involved in intracellular Ca signaling and significantly nant lipase–mediated FA liberation from membrane lipids, contribute to orchestrating oscillations of the intracellular 2+ 2+ by the addition of FA-preloaded FAF-BSA, or by the photol- free Ca concentration ([Ca ]i oscillations) and insulin ysis of cell-impermeant caged FAs. Our combined data secretion. Examples are purinergic receptors that are trig- support the hypothesis of FAs as essential endogenous gered by the auto- and paracrine release of ATP from b-cells signaling factors for b-cell activity and insulin secretion. (8). In 2003, three independent groups reported that GPR40, a G-protein–coupled receptor that is abundantly expressed in the brain and in the pancreas, acts as a recep- In vertebrates, insulin secretion is a synchronized multi- tor for medium- and long-chain fatty acids (FAs) (9–11). cellular process. Sufficiently high blood insulin levels are GPR40 was found to mediate the majority of the effects ensured by the coordinated stimulation of b-cells in pan- that FAs cause on insulin secretion, promoting increased 2+ creatic islets. Coupling of the secretory activity of pancre- [Ca ]i (12,13). Deletion of GPR40 expression in pancre- atic islets results in oscillatory elevations of insulin levels atic b-cells led to resistance toward this FA-induced re- 2+ in the bloodstream (1). Studies on patients with diabetes sponse in [Ca ]i oscillations and insulin secretion (12,14). indicate that under oscillatory infusion of insulin, less GPR40 overexpression, on the other hand, was described to 1Cell Biology and Biophysics Unit, European Molecular Biology Laboratory, This article contains Supplementary Data online at http://diabetes Heidelberg, Germany .diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1215/-/DC1. 2 Department of Physiology and Pharmacology, Oregon Health & Science Univer- © 2018 by the American Diabetes Association. Readers may use this article as sity, Portland, OR long as the work is properly cited, the use is educational and not for profit, and the 3 Institute of Organic Chemistry and Biochemistry, Academy of Sciences of Czech work is not altered. More information is available at http://www.diabetesjournals Republic, Prague, Czech Republic .org/content/license. Corresponding authors: Carsten Schultz, [email protected], and Dmytro A. See accompanying article, p. 1932. Yushchenko, [email protected]. Received 6 October 2017 and accepted 2 May 2018. diabetes.diabetesjournals.org Hauke and Associates 1987 augment glucose-stimulated insulin secretion (GSIS) (15), Isolation and Culture of Mouse Primary b-Cells 2+ pointing to a major role of GPR40 in FA-stimulated [Ca ]i Mouse islets were isolated from C57BL/6 mice (female signaling and GSIS. Recently, we have shown that photo- Ctrl:CD1(ICR), outbred (catalog #CD1S1FE07W; Charles release of arachidonic acid leads to GPR40 stimulation River Laboratories) by collagenase digestion, as previously and subsequent activation of trimeric G-proteins together described (25). Briefly, mice were euthanized by cervical 2+ with [Ca ]i signaling in MIN6 cells (16). For decades, dislocation, and a collagenase solution (1 mg/mL) was elevated levels of FAs in the bloodstream have been de- injected into the bile duct, followed by digestion at 37°C scribed to significantly augment GSIS in isolated islets (17), for 10 min and separation of islets using a Histopaque animals (18), and nonobese human subjects (19). Studies in (Sigma-Aldrich) gradient (1.083 and 1.077 g/mL). Islets rat islets indicate a hypersensitivity of b-cells to glucose were cultured in RPMI medium (supplemented with 10% after prolonged exposure to FAs (20). In turn, clinical FCS, 100 units/mL penicillin, and 100 mg/mL strepto- studies correlated artificial decreases of plasma FA levels mycin) for 24 h. Upon trypsin digestion (5 min at 37°C), with the reduction of insulin secretion, indicating an es- islets were dissociated into single b-cells, which were sential role of circulating FAs for efficient GSIS (21,22). seeded on poly-L-lysine–coated coverslips. Animals were Even though FAs have been discussed as insulin secreta- housed in the European Molecular Biology Laboratory gogues for decades (as reviewed in Nolan et al. [23]), the role animal facilities under veterinarian supervision and the of endogenous FAs in single b-cell activity, intercellular and guidelines of the European Commission (revised directive interislet signaling, and in the synchronization of b-cells 2010/63/EU, and American Veterinary Medical Association has not been investigated so far. In the current study we guidelines 2007). therefore aimed 1) to determine the role of endogenous FAs Mouse Insulin ELISA as essential endogenous signaling factors for b-cell activity ELISA for the specific quantification of insulin was per- and insulin secretion and 2) to examine whether b-cell formed in 96-well format (Mercodia AB, Uppsala, Sweden). activity can be modulated by the removal or replenishment Insulin levels were normalized to the protein content of of endogenous FAs. Our approach to subordinate b-cell MIN6 cells, using a BCA assay (Pierce BCA Protein assay activity and insulin secretion to the presence of endogenous kit; Thermo Fisher Scientific). Experiments for the de- signaling factors, in particular FAs, contributes to a more termination of supernatant (SN) insulin content were detailed and complete understanding of the fundamental performed in quadruplicate per condition. regulation of b-cell activity and insulin secretion. Confocal Laser Scanning Microscopy RESEARCH DESIGN AND METHODS Imaging was performed on a FluoView1200 (catalog #IX83; Olympus) confocal laser-scanning microscope at 37°C (in- Reagents cubator box made by the European Molecular Biology Lab- BSA (FA free [FAF]: catalog #A7030, lot #SLBK9735V; oratory), using Olympus 603 Plan-Apo (numerical aperture conventional: catalog #A7906, lot #SLBR0420V), 13C-oleic, 1.4, oil) or 203 UPLSAPO (numerical aperture 0.75, air) 13C-palmitic, and 13C-decanoic acid were obtained from Sigma- objectives and FluoView software, version 4.2. The images Aldrich (St. Louis, MO). Thermo Fisher Scientific(Carlsbad, were acquired with a Hamamatsu C9100-50 EM-CCD cam- CA) provided gradient-grade Gibco FBS (catalog #16000–044) era. The green channel was imaged using a 488-nm laser and DMEM. Solvents were obtained in the highest analytical 2 line (120 mW/cm , 2.5%) and a 525/50 emission mirror. The grade from Biosolve (Valkenswaard, the Netherlands) and red channel was imaged using a 559-nm laser (120 mW/cm2, Sigma-Aldrich. All other commercially available chemicals 2.0%) and a 643/50 emission filter. Images were acquired and enzymes were purchased from Sigma-Aldrich and Cay- in 4-s intervals (frame time 3.9 s). A pulsed 375-nm laser man Chemical (Ann Arbor, MI). See Supplementary Data for fi (10 MHz) was applied for uncaging experiments in the en- unit de nitions of applied recombinant enzymes. tire field of view for eight frames (3.2 s/frame). The dual scanner setup allowed for simultaneous laser stimulation and Tissue Culture confocal imaging. This permitted the acquisition of cellular – Insulin-secreting MIN6 cells (24) (passage 25 36) were responses that occur during or immediately after laser stim- cultured at 37°C and 8% CO2 in a humidified atmosphere. 2+ ulation. To test changes in [Ca ]i at the single-cell level, MIN6 cells were grown in DMEM containing 4.5 g/L MIN6 cells, grown to 70% confluence in pseudoislets, were glucose, supplemented with 15% FBS and 70 mmol/L incubated with an acetoxymethyl ester of the Ca2+ indicator b-mercaptoethanol (PAN Biotech, Aidenbach, Germany).
Load more

Recommended publications
  • Shape of Glucose, Insulin, C-Peptide Curves During a 3-H Oral Glucose Tolerance Test: Any Relationship with the Degree of Glucose Tolerance?
    Am J Physiol Regul Integr Comp Physiol 300: R941–R948, 2011. First published January 11, 2011; doi:10.1152/ajpregu.00650.2010. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance? Andrea Tura,1 Umberto Morbiducci,2 Stefano Sbrignadello,1 Yvonne Winhofer,3 Giovanni Pacini,1 and Alexandra Kautzky-Willer3 1Metabolic Unit, Institute of Biomedical Engineering, National Research Council, Padova, Italy; 2Department of Mechanics, Politecnico di Torino, Torino, Italy; and 3Department of Internal Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria Submitted 29 September 2010; accepted in final form 14 January 2011 Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, patients and the investigator. Thus, we expect the OGTT to Kautzky-Willer A. Shape of glucose, insulin, C-peptide curves during a 3-h maintain a relevant role in the study of glucose metabolism. oral glucose tolerance test: any relationship with the degree of glucose Up to now, little attention has been devoted to the possible tolerance? Am J Physiol Regul Integr Comp Physiol 300: R941–R948, 2011. information related to the shape of the concentration time First published January 11, 2011; doi:10.1152/ajpregu.00650.2010.—We courses of the OGTT variables. It is true that the results of aimed to analyze the shape of the glucose, insulin, and C-peptide curves some refined models of ␤-cell function, such as that of the during a 3-h oral glucose tolerance test (OGTT). Another aim was defining an index of shape taking into account the whole OGTT pattern.
    [Show full text]
  • SUPPLEMENTARY DATA APPENDIX 1. Limitations of Hba1c
    SUPPLEMENTARY DATA APPENDIX 1. Limitations of HbA1c What is the relationship between metabolic control and HbA1c? To date, overall glycemic control, as measured by HbA1c, remains the established predictor of diabetes outcomes in persons with type 1 and type 2 diabetes, affecting micro- and macro-vascular complications and mortality. The Diabetes Control and Complications Trial (DCCT), followed by the Epidemiology of Diabetes Interventions and Complications (EDIC) study, demonstrated how elevated HbA1c contributes to complications in T1D (1). The United Kingdom Prospective Diabetes Study (UKPDS) confirmed the importance of glycemic control as well as other components of metabolic control, namely blood pressure, on health outcomes in people with diabetes (2). These studies provided the empiric data that serve as the basis for HbA1c targets recommended by most global organizations. These societies, for the most part, recommend target HbA1c levels of <7% (53 mmol/mol) for adults and <7.5% (58 mmol/mol) for children, although several organizations suggest an HbA1c target of ≤6.5% for adults (AACE) (3) as well as youth (4). All groups suggest aiming for an HbA1c as close to normal as possible without severe hypoglycemia while at the same time indicating a need to individualize glycemic targets according to patient age, duration, co-morbidities, and expected life expectancy with ‘less strict’ HbA1c targets for those less healthy (5). Despite advanced treatment tools, including newer pharmacologic agents (with many classes of oral hypoglycemic agents for T2D), various injectables including long- and short-acting insulin analogs) and advanced technologies (such as insulin pens, insulin pumps, and advanced insulin dosing algorithms for use with pumps or injection regimens), a minority of persons with diabetes, globally, achieve recommended HbA1c levels (6).
    [Show full text]
  • Closing in on the Mechanisms of Pulsatile Insulin Secretion
    Diabetes Volume 67, March 2018 351 Closing in on the Mechanisms of Pulsatile Insulin Secretion Richard Bertram,1 Leslie S. Satin,2 and Arthur S. Sherman3 Diabetes 2018;67:351–359 | https://doi.org/10.2337/dbi17-0004 Insulin secretion from pancreatic islet b-cells occurs in b-cells within islets of Langerhans. Although such rhythms a pulsatile fashion, with a typical period of ∼5min.The are ubiquitous across species, we focus on mice, where most basis of this pulsatility in mouse islets has been inves- of the research on b-cell oscillations has been focused. We tigated for more than four decades, and the various theories anticipate that over the next decade much of what we now have been described as either qualitative or mathematical know about mouse islets will be tested in human islets. models. In many cases the models differ in their mech- Pulsatility in insulin secretion reflects oscillations in the anisms for rhythmogenesis, as well as other less important intracellular Ca2+ concentration of islet b-cells, which in PERSPECTIVES IN DIABETES details. In this Perspective, we describe two main classes of fl 2+ turn re ect bursting electrical activity (5). In intact islets, models: those in which oscillations in the intracellular Ca several types of oscillations are commonly observed. Slow concentration drive oscillations in metabolism, and those oscillations have periods typically between 4 and 6 min (Fig. in which intrinsic metabolic oscillations drive oscillations 1A). Fast oscillations are observed in other islets, with peri- in Ca2+ concentration and electrical activity. We then dis- ods typically less than 1 min (Fig.
    [Show full text]
  • The in Vivo Regulation of Pulsatile Insulin Secretion
    Diabetologia /2002) 45: 3±20 Ó Springer-Verlag 2002 Reviews The in vivo regulation of pulsatile insulin secretion N. Pùrksen1 1 Medical Department of Endocrinology and Metabolism, Aarhus University Hospital, Noerrebrogade, 8000 Aarhus C, Denmark Abstract insulin release have not been reviewed previously. This review will focus on the importance of the secre- The presence of oscillations in peripheral insulin con- tory bursts to overall insulin release, and on how insu- centrations has sparked a number of studies evaluat- lin secretion is adjusted by changes in these secretory ing the impact of the insulin release pattern on the ac- bursts. Detection and quantification of secretory tion of insulin on target organs. These have convinc- bursts depend on methods, and the methodology in- ingly shown that equal amounts of insulin presented volved in studies dealing with pulsatile insulin secre- to target organs have improved action when deliv- tion is described. Finally, data suggest that impaired ered in a pulsatile manner. In addition, impaired pulsatile insulin secretion is an early marker for /not absent) pulsatility of insulin secretion has been beta-cell dysfunction in Type II diabetes, and the demonstrated in Type II /non-insulin-dependent) di- role of early detection of impaired pulsatility to pre- abetes mellitus, suggesting a possible mechanism to dict diabetes or to examine mechanisms to cause explain impaired insulin action in Type II diabetes. beta-cell dysfunction is mentioned. [Diabetologia Whereas the regulation of overall insulin secretion /2002) 45: 3±20] has been described in detail, the mechanisms by which this regulation affects the pulsatile insulin Keywords Insulin, pulsatility oscillation, diabetes, secretory pattern, and the relative and absolute con- physiology, secretion, regulation, C peptide.
    [Show full text]
  • Pulsatile Portal Insulin Delivery Enhances Hepatic Insulin Action and Signaling Aleksey V
    ORIGINAL ARTICLE Pulsatile Portal Insulin Delivery Enhances Hepatic Insulin Action and Signaling Aleksey V. Matveyenko,1 David Liuwantara,1 Tatyana Gurlo,1 David Kirakossian,1 Chiara Dalla Man,2 Claudio Cobelli,2 Morris F. White,3 Kyle D. Copps,3 Elena Volpi,4 Satoshi Fujita,4 and Peter C. Butler1 Insulin is secreted as discrete insulin secretory bursts at ;5-min Insulin secretion is regulated by the magnitude of insulin intervals into the hepatic portal vein, these pulses being attenu- pulses (12,13). Thus, hepatocytes are exposed to an oscil- ated early in the development of type 1 and type 2 diabetes mel- lating insulin concentration wave front with an amplitude of litus (T2DM). Intraportal insulin infusions (pulsatile, constant, or ;0.5–1.0 nmol/L in the fasting state and increasing to ;5.0 reproducing that in T2DM) indicated that the pattern of pulsatile nmol/L after meal ingestion (11,12). The vascular anatomy insulin secretion delivered via the portal vein is important for of hepatic sinusoids permits direct exposure of hepatocytes hepatic insulin action and, therefore, presumably for hepatic in- to these insulin oscillations. sulin signaling. To test this, we examined hepatic insulin signaling Since pulsatile insulin delivery in T1DM and T2DM is in rat livers exposed to the same three patterns of portal vein – insulin delivery by use of sequential liver biopsies in anesthetized impaired (14 16), defective pulsatile insulin delivery may rats. Intraportal delivery of insulin in a constant versus pulsatile contribute to diminished hepatic insulin signaling and he- pattern led to delayed and impaired activation of hepatic insulin patic insulin resistance in diabetes.
    [Show full text]
  • Glucose-Induced Cyclic AMP Oscillations Regulate Pulsatile Insulin Secretion" Cell Metabolism, 2008, Vol
    DiVA *http://uu.diva-portal.org This is an author produced version of a paper published in Cell Metabolism. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. Citation for the published paper: Dyachok, Oleg; Idevall-Hagren, Olof; Sågetorp, Jenny; Tian, Geng; Wuttke, Anne; Arrieumerlou, Cécile; Akusjärvi, Göran; Gylfe, Erik; Tengholm, Anders ”Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion" Cell metabolism, 2008, Vol. 8, Issue 1: 26-37 URL: http://dx.doi.org/10.1016/j.cmet.2008.06.003 Access to the published version may require subscription. Published with permission from: Elsevier Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion Oleg Dyachok1,2, Olof Idevall-Hagren1, Jenny Sågetorp1, Geng Tian1, Anne Wuttke1, Cécile Arrieumerlou3, Göran Akusjärvi4, Erik Gylfe1 and Anders Tengholm1* 1Department of Medical Cell Biology, Uppsala University, Biomedical Centre, Box 571, SE- 751 23 Uppsala, Sweden 2Department of Biophysics, Kiev T. Shevchenko National University, 01033, Kiev, Ukraine 3Infection Biology, Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056, Basel, Switzerland 4Department of Medical Biochemistry and Microbiology, Uppsala University, Biomedical Centre, Box 582, 751 23 Uppsala Running title: Glucose-induced cAMP oscillations in β-cells *Correspondence: Anders Tengholm Department of Medical Cell Biology Uppsala University Biomedical Centre, Box 571 SE-751 23 Uppsala Sweden Phone: +46-18-4714481 Fax: +46-18-4714059 E-mail: [email protected] 1 SUMMARY Cyclic AMP (cAMP) and Ca2+ are key regulators of exocytosis in many cells, including insulin-secreting β-cells. Glucose-stimulated insulin secretion from β-cells is pulsatile and 2+ 2+ involves oscillations of the cytoplasmic Ca concentration ([Ca ]i), but little is known about the detailed kinetics of cAMP signalling.
    [Show full text]
  • Measurement of Pulsatile Insulin Secretion: Rationale and Methodology
    H OH metabolites OH Review Measurement of Pulsatile Insulin Secretion: Rationale and Methodology Marcello C. Laurenti 1,2, Aleksey Matveyenko 1 and Adrian Vella 1,* 1 Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic, Rochester, MN 55905, USA; [email protected] (M.C.L.); [email protected] (A.M.) 2 Biomedical Engineering and Physiology Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA * Correspondence: [email protected]; Tel.: +1-507-255-6515; Fax: +1-507-255-4828 Abstract: Pancreatic β-cells are responsible for the synthesis and exocytosis of insulin in response to an increase in circulating glucose. Insulin secretion occurs in a pulsatile manner, with oscillatory pulses superimposed on a basal secretion rate. Insulin pulses are a marker of β-cell health, and secretory parameters, such as pulse amplitude, time interval and frequency distribution, are impaired in obesity, aging and type 2 diabetes. In this review, we detail the mechanisms of insulin production and β-cell synchronization that regulate pulsatile insulin secretion, and we discuss the challenges to consider when measuring fast oscillatory secretion in vivo. These include the anatomical difficulties of measuring portal vein insulin noninvasively in humans before the hormone is extracted by the liver and quickly removed from the circulation. Peripheral concentrations of insulin or C-peptide, a peptide cosecreted with insulin, can be used to estimate their secretion profile, but mathematical deconvolution is required. Parametric and nonparametric approaches to the deconvolution problem are evaluated, alongside the assumptions and trade-offs required for their application in the quantifi- Citation: Laurenti, M.C.; cation of unknown insulin secretory rates from known peripheral concentrations.
    [Show full text]
  • Effect of Insulin Sensitivity on Pulsatile Insulin Secretion
    European Journal of Endocrinology (1999) 141 494–501 ISSN 0804-4643 CLINICAL STUDY Effect of insulin sensitivity on pulsatile insulin secretion MilosˇZˇarkovic´, Jasmina C´iric´, Milosˇ Stojanovic´, Zorana Penezic´,Bozˇo Trbojevic´, Milka Drezgic´ and Milica Nesˇovic´ Institute of Endocrinology, School of Medicine, University of Belgrade, Dr Subotic´a 13, 11000 Belgrade, Yugoslavia (Correspondence should be addressed to Milosˇ Zˇarkovic´; Email: [email protected]) Abstract Objective: The aim of the study was to determine whether derangements in insulin pulsatility are related to the presence of insulin resistance or whether these changes occur only in non-insulin- dependent diabetes mellitus (NIDDM). Design and methods: The study included 26 obese, 11 NIDDM and 10 control subjects. The obese group was divided into a low insulin (plasma insulin <20 mU/l, OLI, 14 subjects) and a high insulin (OHI, 12 subjects) group. For pulsatility analysis blood was sampled every 2 min for 90 min. Pulsatility analysis was carried out using the PulsDetekt program. The insulin secretion randomness was quantified using interpulse interval deviation (IpID) and approximate entropy (ApEn). ApEn and ApEn normalized by S.D. of the individual insulin time series (nApEn) were calculated. Lower values of ApEn and IpID indicate more regular secretion. Homeostasis model assessment (HOMA) was used to quantify insulin sensitivity. Results: Insulin pulses were significantly less regular in the OHI and the NIDDM groups compared with the control and the OLI groups (control: ApEn 0.54 6 0.16, nApEn 0.69 6 0.19, IpID 2.53 6 0.99; OLI: ApEn 0.64 6 0.12, nApEn 0.79 6 0.15, IpID 2.92 6 1.09; OHI: ApEn 0.88 6 0.07, nApEn 0.92 6 0.07, IpID 3.95 6 0.84; NIDDM: ApEn 0.92 6 0.16, nApEn 0.99 6 0.09, IpID 4.41 6 0.53; means 6 S.D.).
    [Show full text]
  • Signaling Underlying Pulsatile Insulin Secretion
    Upsala J Med Sci 105: 2,35-5 1,2000 Signaling Underlying Pulsatile Insulin Secretion Erik Gylfe, Meftun Ahmed, Peter Bergsten, HelCne Dansk, Oleg Dyachok, Michael Eberhardson, Eva Grapengiesser, Bo Hellman, Jian-Man Lin, Tea Sundsten, Anders Tengholm, Elaine Vieira and Johanna Westerlund Department of Medical Cell Biology, Uppsala University, Uppsala Sweden Regular oscillations of the circulating insulin concentrations were discovered in the monkey [28] and subsequently found in normal human subjects [50]. The characte- ristic insulin pattern is deteriorated in patients with type 2 diabetes [49] as well as in their close relatives [6 11. Studies in non-diabetic subjects with suppressed endo- genous insulin secretion and diabetic patients have indicated that less insulin is required to maintain normoglycaemia if the hormone is infused in a pulsatile man- ner compared to a constant rate [12, 57, 59, 63, 641. This difference is probably explained by higher expression of insulin receptors, when insulin is delivered in pulses [27]. It is easy to envision a scenario for the development of type 2 diabetes in which deteriorated oscillations leads to insulin resistance with a compensating hypersecretion of the hormone. In susceptible individuals the increased insulin demand may eventually exhaust the pancreatic p-cells with resulting development of overt diabetes. What is then the origin of the regular insulin oscillations? One possibility is that they result from a negative feedback loop between the liver and the pancreatic p- cell [50]. However, later studies have indicated that the oscillations occur indepen- dent of changes in plasma glucose, reflecting a pacemaker function in the pancreas [49, 581.
    [Show full text]
  • Mathematical Modeling and Simulations of the Pathophysiology of Type-2 Diabetes Mellitus Frank K
    Fayetteville State University DigitalCommons@Fayetteville State University Math and Computer Science Working Papers College of Arts and Sciences 10-2015 Mathematical Modeling and Simulations of the Pathophysiology of Type-2 Diabetes Mellitus Frank K. Nani Fayetteville State University, [email protected] Mingxian Jin Fayetteville State University, [email protected] Follow this and additional works at: http://digitalcommons.uncfsu.edu/macsc_wp Part of the Medical Biomathematics and Biometrics Commons Recommended Citation Nani, Frank K. and Jin, Mingxian, "Mathematical Modeling and Simulations of the Pathophysiology of Type-2 Diabetes Mellitus" (2015). Math and Computer Science Working Papers. Paper 25. http://digitalcommons.uncfsu.edu/macsc_wp/25 This Conference Proceeding is brought to you for free and open access by the College of Arts and Sciences at DigitalCommons@Fayetteville State University. It has been accepted for inclusion in Math and Computer Science Working Papers by an authorized administrator of DigitalCommons@Fayetteville State University. For more information, please contact [email protected]. 2015 8th International Conference on BioMedical Engineering and Informatics (BMEI 2015) Mathematical Modeling and Simulations of the Pathophysiology of Type-2 Diabetes Mellitus Frank Nani and Mingxian Jin Department of Mathematics and Computer Science Fayetteville State University Fayetteville, NC 28301, USA Abstract --The pathophysiology of Type 2 Diabetes Mellitus and cardio-metabolic factors. Recent emerging risk factors (T2DM) is modelled using a coupled system of non-linear include sleep deprivation, drug-induced metabolic changes, deterministic differential equations. An attempt is made to environmental pollutants, low birth weight and fetal construct to a clinically plausible mathematical model that malnutrition [3, 4, 5, 6, 7].
    [Show full text]
  • INAUGURAL-DISSERTATION Martina
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2006 The effect of feeding time on the quality of metabolic control, day-to-day variability of blood glucose curves and evaluation of IGF-1 levels in cats with diabetes mellitus Alt, Martina Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-163497 Dissertation Published Version Originally published at: Alt, Martina. The effect of feeding time on the quality of metabolic control, day-to-day variability of blood glucose curves and evaluation of IGF-1 levels in cats with diabetes mellitus. 2006, University of Zurich, Vetsuisse Faculty. Aus der Klinik für Kleintiermedizin der Vetsuisse-Fakultät Universität Zürich Direktorin: Prof. Dr. C. Reusch Arbeit unter der Leitung von: Prof. Dr. C. Reusch The effect of feeding time on the quality of metabolic control, day-to-day variability of blood glucose curves and evaluation of IGF-1 levels in cats with diabetes mellitus INAUGURAL-DISSERTATION zur Erlangung der Doktorwürde der Vetsuisse-Fakultät Universität Zürich vorgelegt von Martina Alt Tierärztin von Zollikon, Schweiz genehmigt auf Antrag von Prof. Dr. C. Reusch, Referentin Prof. Dr. T. Lutz, Korreferent Zürich 2006 Für Fredi, Trix und Hans zum Dank für die Grosszügigkeit und U nterstützung 2 Contents Summary …………………………………………………………………………………... 5 PART 1: The effect of feeding time on the quality of metabolic control in diabetic cats…………………………………………………………………………………............. 6 1. Introduction .…………………………………………………………………………….. 6 1.1. Literature...…………………………………………………………………….. 6 1.2. Objectives and Hypothesis…………………………………………………….. 7 2. Materials und Methods...…………………..…………………………………………….. 8 2.1.
    [Show full text]
  • Effectiveness and Safety of Pulsatile Intravenous Insulin Therapy for the Improvement of Respiratory Quotient in Chinese Patients with Diabetes Mellitus
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 19: 3069-3075, 2020 Effectiveness and safety of pulsatile intravenous insulin therapy for the improvement of respiratory quotient in Chinese patients with diabetes mellitus NAN GU1, AIMEI DONG1, LEI GAO2, CHENYING XIE1, PEIYI HOU1, WENBO WANG3, SAINAN ZHU4, CHEN YAO4, JUNQING ZHANG1 and XIAOHUI GUO1 1Department of Endocrinology, 2Institute of Clinical Pharmacology, Peking University First Hospital, Beijing 100034; 3Department of Endocrinology, Peking University Shougang Hospital, Beijing 100144; 4Department of Biostatistics, Peking University First Hospital, Beijing 100034, P.R. China Received May 31, 2019; Accepted December 20, 2019 DOI: 10.3892/etm.2020.8563 Abstract. Pulsatile intravenous insulin therapy (PIVIT) is a Registry (http://www.chictr.org.cn) on November 13th 2019 means of imitating naturally occurring insulin pulses arti- (registration no. ChiCTR1900027510). ficially. It is thought to improve carbohydrate metabolism, which can be assessed using the respiratory quotient (RQ). Introduction The aim of this present study was to assess the efficacy and safety of PIVIT for the improvement of RQ in Chinese patients Insulin secretion occurs in a pulsatile manner into the circula- with diabetes mellitus (DM). This 12‑week, multi‑center, tion of humans and animals, with fast pulses occurring every prospective, randomized, open‑label, parallel‑group study 5‑15 min (1,2). Insulin is secreted into the portal vein and involved 110 DM patients (both type 1 and type 2) whose RQ undergoes partial (40‑80%) hepatic extraction, before being was <0.8. Of these, 53 patients formed the control group, in diluted into the systemic insulin pool. Peripheral insulin which standard anti‑diabetic therapy was maintained, and concentrations oscillate because of the pulsatility of insulin 54 patients formed the treatment group, which underwent secretions (3).
    [Show full text]